European Archives - Page 663 of 1131 - European Medical Journal

Pharmacokinetics of Ceftriaxone During Prolonged Intermittent Renal Replacement Therapy in a Patient with Child–Pugh B Cirrhosis and Ascites

Prolonged intermittent renal replacement therapy (PIRRT) is emerging as an alternative to continuous renal replacement therapy as renal support for the critically ill.

Mepolizumab Therapy in Eosinophilic Granulomatosis with Polyangiitis: 1-Year Follow-Up Study Using Anti-IL-5 as a Steroid Sparing Therapeutic Approach

Eosinophilic granulomatosis with polyangiitis (EGPA) is a small vessel vasculitis characterised by the presence of tissue eosinophilia…

Acute Kidney Injury: Risk Factors and Management Challenges in Low- and Middle-Income Countries

Acute kidney injury (AKI) is a major global health problem, occurring in >13 million people and responsible for >2.3 million deaths every year, 85% of which are in developing countries.

Use of Rituximab for Glomerular Diseases Indicated Versus Off-Label: Clinical Perspective

Rituximab (RTX) is used worldwide for the treatment of glomerulonephritis (GN), including membranous glomerulopathy (MN), minimal change disease (MCD)…

Diabetic Kidney Disease in Childhood and Adolescence: Conventional and Novel Renoprotective Strategies

Diabetic kidney disease (DKD) is defined as a clinical syndrome consisting of persistent macroalbuminuria

Pharmacokinetics of Amoxicillin and Cefepime During Prolonged Intermittent Renal Replacement Therapy: A Case Report

Prolonged intermittent renal replacement therapy (PIRRT) is an emerging form of renal replacement therapy in critically ill patients, but dosing data…

Chronic Interstitial Nephritis in Agricultural Communities: A Toxin-Induced Proximal Tubular Nephropathy

In the early 1990s, clinicians in Central America and Sri Lanka noticed an upsurge of chronic kidney disease (CKD) in agricultural communities…

Barriers to Home Haemodialysis in Saskatchewan Canada: Results from a Provincial Survey

Despite clinical and lifestyle advantages of home haemodialysis (HHD) compared to in-centre hemodialysis,1 it remains underutilised in the province of…

The Benefits of PGT-A, PGT-M, and Expanded Carrier Screening in IVF Research

In this webinar, Murat Çetinkaya and Volkan Baltaci discuss the advantages of PGT-A, PGT-M, and carrier screening in IVF research, molecular technologies improving workflows in IVF, and how IVF research labs are benefiting from cutting edge NGS technologies.

Talking to Steve Ingham

Steve Ingham, leading performance scientist and founder of the performance consultancy, Supporting Champions, talks about his work with the British Olympic team, how to earn the respect of high performers, and what businesses can learn from the mindsets of professional athletes.